title: Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells.
abstract: The T cell product interleukin 5 (IL-5) has been shown to be a key factor in the development and the maturation of the eosinophilic cell lineage. We report here on the detection of human IL-5 receptors on eosinophilic sublines of the promyelocytic leukemia HL-60. Sodium butyrate, which initiates differentiation to mature eosinophils, also induces the appearance of high affinity (Kd 1-5 X 10(-11) M) IL-5 binding sites on these cells. The receptors are specific for IL-5, since binding of radiolabeled ligand can only be inhibited with homologous or murine IL-5 and not by other cytokines. We further show that the receptors are functional, since IL-5 can stimulate the proliferation of these cells. Affinity crosslinking of surface-bound 125I human IL-5 or 35S mouse IL-5 identified two membrane polypeptides of approximately 60 and approximately 130 kD to which IL-5 is closely associated. The presence of granulocyte/macrophage-colony-stimulating factor or tumor necrosis factor during butyrate induction decreased the expression of IL-5 binding sites compared with control cultures. The identification and characterization of human IL-5 receptors on HL-60 sublines should provide new insight into the role of this cytokine in eosinophil differentiation.
authors.affiliation: Roche Research Gent, Ghent, Belgium.
authors.forename: G
authors.initials: G
authors.lastname: Plaetinck
authors.forename: J
authors.initials: J
authors.lastname: Van der Heyden
authors.forename: J
authors.initials: J
authors.lastname: Tavernier
authors.forename: I
authors.initials: I
authors.lastname: Faché
authors.forename: T
authors.initials: T
authors.lastname: Tuypens
authors.forename: S
authors.initials: S
authors.lastname: Fischkoff
authors.forename: W
authors.initials: W
authors.lastname: Fiers
authors.forename: R
authors.initials: R
authors.lastname: Devos
mesh_terms: D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002460:Cell Line; D002999:Clone Cells; D004804:Eosinophils / Q000276:immunology*; D006801:Humans; D015848:Interleukin-5 / Q000378:metabolism*; D007700:Kinetics; D015473:Leukemia, Promyelocytic, Acute; D011971:Receptors, Immunologic / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism*; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000276:immunology*
chemical_list: D002087:Butyrates; D015848:Interleukin-5; D011971:Receptors, Immunologic; D018123:Receptors, Interleukin; D053649:Receptors, Interleukin-5; D020148:Butyric Acid